Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Couanet

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation|October 3, 1998
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumorsN Lucidarme, D Valteau-Couanet, O Oberlin, et al.
Annales De Radiologie|November 1, 1984
[Strategy of radiological exploration in Hodgkin's disease]J Masselot, J M Cosset, D Couanet, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Bone Marrow Transplantation|September 27, 2005
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacyD Valteau-Couanet, B Fillipini, E Benhamou, et al.
Bone Marrow Transplantation|May 7, 1999
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institutionO Hartmann, D Valteau-Couanet, G Vassal, et al.
Journal of Child Neurology|September 29, 2001
Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girlV Kieffer-Renaux, C Bulteau, J Grill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Phase II trial of thalidomide in renal-cell carcinomaB Escudier, N Lassau, D Couanet, et al.
Bone Marrow Transplantation|April 1, 1992
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II studyC Kalifa, O Hartmann, F Demeocq, et al.
Medical and Pediatric Oncology|January 1, 1994
What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?C Labreveux de Cervens, O Hartmann, F Bonnin, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation|October 3, 1998
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumorsN Lucidarme, D Valteau-Couanet, O Oberlin, et al.
Annales De Radiologie|November 1, 1984
[Strategy of radiological exploration in Hodgkin's disease]J Masselot, J M Cosset, D Couanet, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Bone Marrow Transplantation|September 27, 2005
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacyD Valteau-Couanet, B Fillipini, E Benhamou, et al.
Bone Marrow Transplantation|May 7, 1999
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institutionO Hartmann, D Valteau-Couanet, G Vassal, et al.
Journal of Child Neurology|September 29, 2001
Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girlV Kieffer-Renaux, C Bulteau, J Grill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Phase II trial of thalidomide in renal-cell carcinomaB Escudier, N Lassau, D Couanet, et al.
Bone Marrow Transplantation|April 1, 1992
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II studyC Kalifa, O Hartmann, F Demeocq, et al.
Medical and Pediatric Oncology|January 1, 1994
What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?C Labreveux de Cervens, O Hartmann, F Bonnin, et al.
Pageof 8